Immunocore Holdings plc - ADR

NASDAQ:IMCR   3:59:50 PM EDT
28.64
-0.89 (-3.01%)
Earnings Announcements

Immunocore Reports First Quarter 2022 Financial Results And Provides Business Update

Published: 05/11/2022 11:18 GMT
Immunocore Holdings plc - ADR (IMCR) - Immunocore Reports First Quarter 2022 Financial Results and Provides Business Update.
Q1 Loss per Share GBP 0.37.
Cash and Cash Equivalents Were £205.9 Million Or Approximately $270.7 Million As of March 31, 2022.
Q1 Earnings per Share View -84.50 Pence -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $19.37 Million
Adjusted EPS is expected to be -$0.81

Next Quarter Revenue Guidance is expected to be $21.29 Million
Next Quarter EPS Guidance is expected to be -$0.83

More details on our Analysts Page.